Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) (CENTAUR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03127514
Recruitment Status : Active, not recruiting
First Posted : April 25, 2017
Last Update Posted : October 10, 2019
Sponsor:
Collaborators:
ALS Finding a Cure Foundation
ALS Association
Northeast ALS Consortium
Massachusetts General Hospital Neurology Clinical Research Institute
Leandro P. Rizzuto Foundation
Information provided by (Responsible Party):
Amylyx Pharmaceuticals Inc.